Willie Heard is a man of faith. His faith stood strong even after he got tragic news in September 2013. Heard was diagnosed with Myelodysplastic syndromes (MDS), a group of bone marrow cancers in which the bone marrow does not produce enough healthy blood cells. His cancer diagnosis came just months after retiring from his job at USAA and just shy of his 67th birthday. “I’m a religious person and a minister and, I think I remember telling the doctor, I said, ‘Doctor you do what you do, I’m gonna let God do what he does,’” said Heard, a resident of San Antonio, Texas. “[The cancer diagnosis] was a surprise to me, but I’ve always been a person that don’t really worry about stuff I can’t control, so I don’t let that bother me.”
Heard’s Decision to ...
Willie Heard es un hombre de fe. Su fe se mantuvo fuerte incluso después de recibir noticias trágicas en septiembre de 2013. Heard fue diagnosticado con síndrome mielodisplásico (SMD), un grupo de cánceres de médula ósea en los que la médula ósea no produce suficientes células sanguíneas sanas. Él recibió el diagnóstico de cáncer pocos meses después de retirarse de su trabajo en USAA y justo antes de cumplir 67 años de edad. "Soy una persona religiosa y un ministro y, creo que recuerdo haberle dicho al doctor, le dije: 'Doctor, haga lo que usted hace, y yo voy a dejar que Dios haga lo que Él hace'", dijo Heard, un residente de San Antonio, Texas. "[El diagnóstico de cáncer] fue una sorpresa para mí, pero siempre he sido una persona que realmente no se ...
Alzheimer’s patients and their loved ones have new reason for hope after positive results from clinical trial of a new treatment called lecanemab. Lecanemab – a drug designed to slow the progression of Alzheimer’s disease by targeting amyloid plaque buildup in the brain – reduced the progression of cognitive decline among trial participants by 27% over 18 months, compared to placebo, according to UsAgainstAlzheimers. “This is very important and quite positive news that gives our nation’s 6 million Alzheimer’s patients and their loved ones reason to hope again. In fact, the data is a reminder that each drug in this class of therapies is quite different,” said George Vradenburg, chair and co-founder of UsAgainstAlzheimers. What do the results show, and how will ...
Leonel Rodriguez got some terrible news in November 2019. Doctors diagnosed Rodriguez, a South Texas resident, with mantle cell lymphoma – an aggressive, rare form of non-Hodgkin lymphoma. The first medicines he took to treat the cancer actually worsened his condition. He soon learned about a potentially beneficial clinical trial for lymphoma patients at the Mays Cancer Center at UT Health San Antonio. Clinical trials help researchers learn how to better slow, manage, and treat diseases like cancer and Alzheimer’s. “[Clinical trials were] the best way because, you know, I feel good now with the treatment,” Rodriguez said. “Now I feel I've been feeling well, and well, well.”
Rodriguez’s Decision to Participate in a Clinical Trial
Rodriguez has come full circle ...
Leonel Rodríguez recibió una noticia terrible en noviembre de 2019. Los médicos diagnosticaron a Rodríguez, un residente del sur de Texas, con linfoma de células del manto, una forma agresiva y rara de linfoma no Hodgkin. Los primeros medicamentos que tomó para tratar el cáncer en realidad empeoraron su condición. Pronto se enteró de un estudio clínico potencialmente beneficioso para pacientes con linfoma ofrecido por el Mays Cancer Center de UT Health San Antonio. Los estudios clínicos ayudan a los investigadores a aprender cómo reducir el progreso, manejar y tratar mejor enfermedades como el cáncer y el Alzheimer. "[Los estudios clínicos fueron] la mejor manera porque, usted sabe, ahora me siento bien con el tratamiento", dijo Rodríguez. "Ahora siento que me ...
By 2030, 40% of Alzheimer’s patients in the U.S. will be Latino or Black. However, Latinos make up less than 1% of participants in National Institutes of Health clinical trials. Clinical trials are studies that help researchers learn more to help slow, manage, and treat Alzheimer’s and cancer for current and future family members. Without Latino volunteers for clinical trials, the benefits may miss this group. With Compadre CART at the Biggs Institute for Alzheimer’s & Neurodegenerative Diseases at UT Health San Antonio participants have the opportunity to help an underrepresented, high-risk group maintain independence with aging. To participate, contact Luis Serranorubio of the research team at 210-450-8447.
Compadre CART Study Goals
To learn more about why ...
Stress is a grim reality for many Latinas after breast cancer. Survivors deal with health, fitness, finance, discrimination, and social challenges that reduce their quality of life and boost their risk of new or recurring cancers. That is why Drs. Amelie G. Ramirez, Daniel Carlos Hughes, and Patricia Chalela at UT Health San Antonio will conduct a holistic intervention to improve Latina breast cancer survivors' physical, mental, and spiritual well-being, thanks to a new, three-year, $600,000 grant from Susan G. Komen. Researchers will recruit 70 breast cancer survivors, half of them Latinas. Over six months, they will get: therapeutic yoga with meditation
optional tailored exercise and diet counseling
real-time psycho-social support based on survivors’ ...
Bladder cancer is the fourth most common cancer in men and causes about 17,100 deaths annually in the US. About 75% of bladder cancer cases are non-muscle invasive. This means that the cancer affects the tissue lining of the inner surface of the bladder, but not the bladder muscle. While this type of bladder cancer is treatable, one of the most effective treatments for this disease – a tuberculosis vaccine – causes intolerable side effects for up to 84% of patients, which can prevent treatment completion. When treatments fail, the bladder may have to be removed, reducing the patient’s quality of life. However, a modified tuberculosis vaccine developed by Jordi B. Torrelles, PhD, a professor at Texas Biomedical Research Institute in San Antonio, could help treat non-muscle ...
From merengue to salsa, dance and music are at the heart of the Latino community. Latin dance celebrates culture, history, family, and joyous occasions. Now Latin dance is proving to help the working memory of older Latinos. Latinos age 55 or older who participated in a culturally relevant Latin dance program for 8 months significantly improved their working memory, compared to other peers in a controlled group that attended educational workshops, according to a recent study by researchers from the University of Illinois Urbana-Champaign. Let’s explore why Latin dance is so beneficial.
What Did the Latin Dance Study Explore?
The recent study examined changes in cognitive performance among over 330 middle-aged and older Latinos participating in the Balance and Activity in ...
